Cargando…

Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study

BACKGROUND: Hepatitis E, an acute zoonotic disease caused by the hepatitis E virus (HEV), has a relatively high burden in developing countries. The current research model on hepatitis E mainly uses experimental animal models (such as pigs, chickens, and rabbits) to explain the transmission of HEV. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meng, Cheng, Xiao-Qing, Zhao, Ze-Yu, Li, Pei-Hua, Rui, Jia, Lin, Sheng-Nan, Xu, Jing-Wen, Zhu, Yuan-Zhao, Wang, Yao, Liu, Xing-Chun, Luo, Li, Deng, Bin, Liu, Chan, Huang, Jie-Feng, Yang, Tian-Long, Li, Zhuo-Yang, Liu, Wei-Kang, Liu, Wen-Dong, Zhao, Ben-Hua, He, Yue, Yin, Qi, Mao, Si-Ying, Su, Yan-Hua, Zhang, Xue-Feng, Chen, Tian-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240442/
https://www.ncbi.nlm.nih.gov/pubmed/34187566
http://dx.doi.org/10.1186/s40249-021-00873-w
_version_ 1783715218768003072
author Yang, Meng
Cheng, Xiao-Qing
Zhao, Ze-Yu
Li, Pei-Hua
Rui, Jia
Lin, Sheng-Nan
Xu, Jing-Wen
Zhu, Yuan-Zhao
Wang, Yao
Liu, Xing-Chun
Luo, Li
Deng, Bin
Liu, Chan
Huang, Jie-Feng
Yang, Tian-Long
Li, Zhuo-Yang
Liu, Wei-Kang
Liu, Wen-Dong
Zhao, Ben-Hua
He, Yue
Yin, Qi
Mao, Si-Ying
Su, Yan-Hua
Zhang, Xue-Feng
Chen, Tian-Mu
author_facet Yang, Meng
Cheng, Xiao-Qing
Zhao, Ze-Yu
Li, Pei-Hua
Rui, Jia
Lin, Sheng-Nan
Xu, Jing-Wen
Zhu, Yuan-Zhao
Wang, Yao
Liu, Xing-Chun
Luo, Li
Deng, Bin
Liu, Chan
Huang, Jie-Feng
Yang, Tian-Long
Li, Zhuo-Yang
Liu, Wei-Kang
Liu, Wen-Dong
Zhao, Ben-Hua
He, Yue
Yin, Qi
Mao, Si-Ying
Su, Yan-Hua
Zhang, Xue-Feng
Chen, Tian-Mu
author_sort Yang, Meng
collection PubMed
description BACKGROUND: Hepatitis E, an acute zoonotic disease caused by the hepatitis E virus (HEV), has a relatively high burden in developing countries. The current research model on hepatitis E mainly uses experimental animal models (such as pigs, chickens, and rabbits) to explain the transmission of HEV. Few studies have developed a multi-host and multi-route transmission dynamic model (MHMRTDM) to explore the transmission feature of HEV. Hence, this study aimed to explore its transmission and evaluate the effectiveness of intervention using the dataset of Jiangsu Province. METHODS: We developed a dataset comprising all reported HEV cases in Jiangsu Province from 2005 to 2018. The MHMRTDM was developed according to the natural history of HEV cases among humans and pigs and the multi-transmission routes such as person-to-person, pig-to-person, and environment-to-person. We estimated the key parameter of the transmission using the principle of least root mean square to fit the curve of the MHMRTDM to the reported data. We developed models with single or combined countermeasures to assess the effectiveness of interventions, which include vaccination, shortening the infectious period, and cutting transmission routes. The indicator, total attack rate (TAR), was adopted to assess the effectiveness. RESULTS: From 2005 to 2018, 44 923 hepatitis E cases were reported in Jiangsu Province. The model fits the data well (R(2) = 0.655, P < 0.001). The incidence of the disease in Jiangsu Province and its cities peaks are around March; however, transmissibility of the disease peaks in December and January. The model showed that the most effective intervention was interrupting the pig-to-person route during the incidence trough of September, thereby reducing the TAR by 98.11%, followed by vaccination (reducing the TAR by 76.25% when the vaccination coefficient is 100%) and shortening the infectious period (reducing the TAR by 50.05% when the infectious period is shortened to 15 days). CONCLUSIONS: HEV could be controlled by interrupting the pig-to-person route, shortening the infectious period, and vaccination. Among these interventions, the most effective was interrupting the pig-to-person route. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00873-w.
format Online
Article
Text
id pubmed-8240442
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82404422021-06-29 Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study Yang, Meng Cheng, Xiao-Qing Zhao, Ze-Yu Li, Pei-Hua Rui, Jia Lin, Sheng-Nan Xu, Jing-Wen Zhu, Yuan-Zhao Wang, Yao Liu, Xing-Chun Luo, Li Deng, Bin Liu, Chan Huang, Jie-Feng Yang, Tian-Long Li, Zhuo-Yang Liu, Wei-Kang Liu, Wen-Dong Zhao, Ben-Hua He, Yue Yin, Qi Mao, Si-Ying Su, Yan-Hua Zhang, Xue-Feng Chen, Tian-Mu Infect Dis Poverty Research Article BACKGROUND: Hepatitis E, an acute zoonotic disease caused by the hepatitis E virus (HEV), has a relatively high burden in developing countries. The current research model on hepatitis E mainly uses experimental animal models (such as pigs, chickens, and rabbits) to explain the transmission of HEV. Few studies have developed a multi-host and multi-route transmission dynamic model (MHMRTDM) to explore the transmission feature of HEV. Hence, this study aimed to explore its transmission and evaluate the effectiveness of intervention using the dataset of Jiangsu Province. METHODS: We developed a dataset comprising all reported HEV cases in Jiangsu Province from 2005 to 2018. The MHMRTDM was developed according to the natural history of HEV cases among humans and pigs and the multi-transmission routes such as person-to-person, pig-to-person, and environment-to-person. We estimated the key parameter of the transmission using the principle of least root mean square to fit the curve of the MHMRTDM to the reported data. We developed models with single or combined countermeasures to assess the effectiveness of interventions, which include vaccination, shortening the infectious period, and cutting transmission routes. The indicator, total attack rate (TAR), was adopted to assess the effectiveness. RESULTS: From 2005 to 2018, 44 923 hepatitis E cases were reported in Jiangsu Province. The model fits the data well (R(2) = 0.655, P < 0.001). The incidence of the disease in Jiangsu Province and its cities peaks are around March; however, transmissibility of the disease peaks in December and January. The model showed that the most effective intervention was interrupting the pig-to-person route during the incidence trough of September, thereby reducing the TAR by 98.11%, followed by vaccination (reducing the TAR by 76.25% when the vaccination coefficient is 100%) and shortening the infectious period (reducing the TAR by 50.05% when the infectious period is shortened to 15 days). CONCLUSIONS: HEV could be controlled by interrupting the pig-to-person route, shortening the infectious period, and vaccination. Among these interventions, the most effective was interrupting the pig-to-person route. GRAPHIC ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00873-w. BioMed Central 2021-06-29 /pmc/articles/PMC8240442/ /pubmed/34187566 http://dx.doi.org/10.1186/s40249-021-00873-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Meng
Cheng, Xiao-Qing
Zhao, Ze-Yu
Li, Pei-Hua
Rui, Jia
Lin, Sheng-Nan
Xu, Jing-Wen
Zhu, Yuan-Zhao
Wang, Yao
Liu, Xing-Chun
Luo, Li
Deng, Bin
Liu, Chan
Huang, Jie-Feng
Yang, Tian-Long
Li, Zhuo-Yang
Liu, Wei-Kang
Liu, Wen-Dong
Zhao, Ben-Hua
He, Yue
Yin, Qi
Mao, Si-Ying
Su, Yan-Hua
Zhang, Xue-Feng
Chen, Tian-Mu
Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title_full Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title_fullStr Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title_full_unstemmed Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title_short Feasibility of controlling hepatitis E in Jiangsu Province, China: a modelling study
title_sort feasibility of controlling hepatitis e in jiangsu province, china: a modelling study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240442/
https://www.ncbi.nlm.nih.gov/pubmed/34187566
http://dx.doi.org/10.1186/s40249-021-00873-w
work_keys_str_mv AT yangmeng feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT chengxiaoqing feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT zhaozeyu feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT lipeihua feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT ruijia feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT linshengnan feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT xujingwen feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT zhuyuanzhao feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT wangyao feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT liuxingchun feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT luoli feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT dengbin feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT liuchan feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT huangjiefeng feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT yangtianlong feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT lizhuoyang feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT liuweikang feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT liuwendong feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT zhaobenhua feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT heyue feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT yinqi feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT maosiying feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT suyanhua feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT zhangxuefeng feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy
AT chentianmu feasibilityofcontrollinghepatitiseinjiangsuprovincechinaamodellingstudy